{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:36:29Z","timestamp":1770456989188,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T00:00:00Z","timestamp":1570233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.nefro.2019.07.002","type":"journal-article","created":{"date-parts":[[2019,11,10]],"date-time":"2019-11-10T07:17:26Z","timestamp":1573370246000},"page":"142-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Recomendaciones de manejo de la afectaci\u00f3n renal en el complejo esclerosis tuberosa"],"prefix":"10.1016","volume":"40","author":[{"given":"Gema","family":"Ariceta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Buj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Furlano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Matamala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00e1s Roberto","family":"Robles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laia","family":"Sans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Villacampa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roser","family":"Torra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2019.07.002_bib0245","article-title":"Tuberous Sclerosis Complex","author":"Northrup","year":"1993","journal-title":"GeneReviews\u00ae"},{"key":"10.1016\/j.nefro.2019.07.002_bib0250","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol."},{"key":"10.1016\/j.nefro.2019.07.002_bib0255","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol."},{"key":"10.1016\/j.nefro.2019.07.002_bib0260","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.medcli.2016.04.004","article-title":"Recommendations for the multidisciplinary management of tuberous sclerosis complex","volume":"147","author":"Macaya","year":"2016","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.nefro.2019.07.002_bib0265","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00428-007-0509-1","article-title":"PEComas: The past, the present and the future","volume":"452","author":"Martignoni","year":"2008","journal-title":"Virchows Arch."},{"key":"10.1016\/j.nefro.2019.07.002_bib0270","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ajmg.c.31654","article-title":"Renal manifestation of tuberous sclerosis complex","volume":"178","author":"Bissler","year":"2018","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"10.1016\/j.nefro.2019.07.002_bib0275","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","article-title":"Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors","volume":"70","author":"Rakowski","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2019.07.002_bib0280","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1523-1755.2004.00838.x","article-title":"Renal angiomyolipomata","volume":"66","author":"Bissler","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2019.07.002_bib0285","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.urology.2016.04.027","article-title":"Long-term clinical morbidity in patients with renal angiomyolipoma associated with tuberous sclerosis complex","volume":"95","author":"Bissler","year":"2016","journal-title":"Urology."},{"key":"10.1016\/j.nefro.2019.07.002_bib0290","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2015.05.016","article-title":"Long-term follow-up assessing renal angiomyolipoma treatment patterns morbidity, and mortality: An observational study in tuberous sclerosis complex patients in the Netherlands","volume":"66","author":"Eijkemans","year":"2015","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2019.07.002_bib0295","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1080\/03007995.2017.1313726","article-title":"Natural history of patients with tuberous sclerosis complex related renal angiomyolipoma","volume":"33","author":"Song","year":"2017","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.nefro.2019.07.002_bib0300","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eururo.2016.01.048","article-title":"Natural history of renal angiomyolipoma (AML): Most patients with large AMLs >4cm can be offered active surveillance as an initial management strategy","volume":"70","author":"Bhatt","year":"2016","journal-title":"Eur Urol."},{"key":"10.1016\/j.nefro.2019.07.002_bib0305","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/PAS.0b013e31817ed7a6","article-title":"Renal angiomyolipoma: Clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association","volume":"33","author":"Aydin","year":"2009","journal-title":"Am J Surg Pathol."},{"key":"10.1016\/j.nefro.2019.07.002_bib0310","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ckj\/sfx094","article-title":"Recommendations for imaging-based diagnosis and management of renal angiomyolipoma associated with tuberous sclerosis complex","volume":"10","author":"Buj Pradilla","year":"2017","journal-title":"Clin Kidney J."},{"key":"10.1016\/j.nefro.2019.07.002_bib0315","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1148\/rg.351130016","article-title":"CT and MR imaging for evaluation of cystic renal lesions and diseases","volume":"35","author":"Wood","year":"2015","journal-title":"Radiographics."},{"key":"10.1016\/j.nefro.2019.07.002_bib0320","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2214\/AJR.13.11058","article-title":"Comparison of T2-weighted MRI with and without fat suppression for differentiating renal angiomyolipomas without visible fat from other renal tumors","volume":"202","author":"Chung","year":"2014","journal-title":"AJR Am J Roentgenol."},{"key":"10.1016\/j.nefro.2019.07.002_bib0325","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1148\/radiol.12112087","article-title":"Angiomyolipoma with minimal fat: Can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?","volume":"265","author":"Hindman","year":"2012","journal-title":"Radiology."},{"key":"10.1016\/j.nefro.2019.07.002_bib0330","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.crad.2005.01.009","article-title":"Tuberose sclerosis complex: Analysis of growth rates aids differentiation of renal cell carcinoma from atypical or minimal-fat-containing angiomyolipoma","volume":"60","author":"Patel","year":"2005","journal-title":"Clin Radiol."},{"key":"10.1016\/j.nefro.2019.07.002_bib0335","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1148\/radiol.2401050061","article-title":"Renal masses in the adult patient: The role of percutaneous biopsy","volume":"240","author":"Silverman","year":"2006","journal-title":"Radiology."},{"key":"10.1016\/j.nefro.2019.07.002_bib0340","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/archdischild-2013-304948","article-title":"Annual review of children with tuberous sclerosis","volume":"100","author":"Ng","year":"2015","journal-title":"Arch Dis Child Educ Pract Ed."},{"key":"10.1016\/j.nefro.2019.07.002_bib0345","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000448293","article-title":"Review of the tuberous sclerosis renal guidelines from the 2012 consensus conference: Current data and future study","volume":"134","author":"Kingswood","year":"2016","journal-title":"Nephron."},{"key":"10.1016\/j.nefro.2019.07.002_bib0350","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.juro.2015.04.081","article-title":"Transarterial embolization of angiomyolipoma: A systematic review","volume":"194","author":"Murray","year":"2015","journal-title":"J Urol."},{"key":"10.1016\/j.nefro.2019.07.002_bib0355","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/03007995.2017.1286307","article-title":"Outcomes of angioembolization and nephrectomy for renal angiomyolipoma associated with tuberous sclerosis complex: A real-world US national study","volume":"33","author":"Sun","year":"2017","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.nefro.2019.07.002_bib0360","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11934-017-0687-6","article-title":"The role of interventional radiology techniques in the management of renal angiomyolipomas","volume":"18","author":"Kiefer","year":"2017","journal-title":"Curr Urol Rep."},{"key":"10.1016\/j.nefro.2019.07.002_bib0365","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/01443615.2013.812622","article-title":"Renal angiomyolipoma and lymphangioleiomyomatosis in pregnancy","volume":"33","author":"Iruloh","year":"2013","journal-title":"J Obstet Gynaecol (Lahore)."},{"key":"10.1016\/j.nefro.2019.07.002_bib0370","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1203\/PDR.0b013e318183f132","article-title":"Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry","volume":"64","author":"Hopkin","year":"2008","journal-title":"Pediatr Res."},{"key":"10.1016\/j.nefro.2019.07.002_bib0375","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.juro.2011.04.082","article-title":"Selective arterial embolization of angiomyolipomas: A comparison of smaller and larger embolic agents","volume":"186","author":"Villalta","year":"2011","journal-title":"J Urol."},{"key":"10.1016\/j.nefro.2019.07.002_bib0380","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.urology.2008.09.005","article-title":"Percutaneous renal cryoablation of angiomyolipomas in patients with solitary kidneys","volume":"74","author":"Johnson","year":"2009","journal-title":"Urology."},{"key":"10.1016\/j.nefro.2019.07.002_bib0385","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1185\/03007995.2015.1060212","article-title":"Rates of interventional procedures in patients with tuberous sclerosis complex-related renal angiomyolipoma","volume":"31","author":"Bissler","year":"2015","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.nefro.2019.07.002_bib0390","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/0284185113519357","article-title":"Ultrasound-guided percutaneous microwave ablation of sporadic renal angiomyolipoma: Preliminary results","volume":"56","author":"Han","year":"2015","journal-title":"Acta Radiol."},{"key":"10.1016\/j.nefro.2019.07.002_bib0395","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/gfv249","article-title":"Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: Extension of a randomized controlled trial","volume":"31","author":"Bissler","year":"2016","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2019.07.002_bib0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180939","article-title":"Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study","volume":"12","author":"Bissler","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.nefro.2019.07.002_bib0405","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jcph.428","article-title":"Safety considerations of mammalian target of rapamycin inhibitors in tuberous sclerosis complex and renal transplantation","volume":"55","author":"Somers","year":"2015","journal-title":"J Clin Pharmacol."},{"key":"10.1016\/j.nefro.2019.07.002_bib0410","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/ndt\/gfy132","article-title":"Effect of everolimus on renal function in patients with tuberous sclerosis complex: Evidence from EXIST-1 and EXIST-2","volume":"34","author":"Bissler","year":"2019","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2019.07.002_bib0415","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clbc.2014.07.002","article-title":"Everolimus-induced hematologic changes in patients with metastatic breast cancer","volume":"15","author":"Chen","year":"2015","journal-title":"Clin Breast Cancer."},{"key":"10.1016\/j.nefro.2019.07.002_bib0420","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.trre.2014.03.002","article-title":"Strategies for the management of adverse events associated with mTOR inhibitors","volume":"28","author":"Kaplan","year":"2014","journal-title":"Transplant Rev."},{"key":"10.1016\/j.nefro.2019.07.002_bib0425","first-page":"295","article-title":"Practical management of everolimus-related toxicities in patients with advanced solid tumors","volume":"36","author":"Gr\u00fcnwald","year":"2013","journal-title":"Onkologie."},{"key":"10.1016\/j.nefro.2019.07.002_bib0430","first-page":"11","article-title":"Bioavailability of everolimus administered as a single 5mg tablet versus five 1mg tablets: A randomized, open-label, two-way crossover study of healthy volunteers","volume":"7","author":"Thudium","year":"2015","journal-title":"Clin Pharmacol."},{"key":"10.1016\/j.nefro.2019.07.002_bib0435","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1 disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet."},{"key":"10.1016\/j.nefro.2019.07.002_bib0440","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1294-328","article-title":"Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease \u2014 a contiguous gene syndrome","volume":"8","author":"Brook-Carter","year":"1994","journal-title":"Nat Genet."},{"key":"10.1016\/j.nefro.2019.07.002_bib0445","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00247-014-3147-1","article-title":"Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: A contiguous gene syndrome","volume":"45","author":"Back","year":"2015","journal-title":"Pediatr Radiol."},{"key":"10.1016\/j.nefro.2019.07.002_bib0450","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1148\/radiol.2018181243","article-title":"Imaging of kidney cysts and cystic kidney diseases in children: An international working group consensus statement","volume":"290","author":"Gimpel","year":"2019","journal-title":"Radiology."},{"key":"10.1016\/j.nefro.2019.07.002_bib0455","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/IJNRD.S123638","article-title":"Early manifestations of renal disease in patients with tuberous sclerosis complex","author":"Malaga-Dieguez","year":"2017","journal-title":"Int J Nephrol Renovasc Dis."},{"key":"10.1016\/j.nefro.2019.07.002_bib0460","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/08037051.2014.868629","article-title":"2013 ESH\/ESC practice guidelines for the management of arterial hypertension","volume":"23","author":"Mancia","year":"2014","journal-title":"Blood Press."},{"key":"10.1016\/j.nefro.2019.07.002_bib0465","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics."},{"key":"10.1016\/j.nefro.2019.07.002_bib0470","doi-asserted-by":"crossref","first-page":"F560","DOI":"10.1152\/ajprenal.00569.2013","article-title":"Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy","volume":"307","author":"Siroky","year":"2014","journal-title":"Am J Physiol Renal Physiol."},{"key":"10.1016\/j.nefro.2019.07.002_bib0475","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2215\/CJN.07371009","article-title":"Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipients","volume":"5","author":"Duerr","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2019.07.002_bib0480","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00134-014-3290-z","article-title":"Angioedema induced by angiotensin converting enzyme inhibitors, potentiated by m-TOR inhibitors: Successful treatment with icatibant","volume":"40","author":"Charmillon","year":"2014","journal-title":"Intensive Care Med."}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699519301560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699519301560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:53:47Z","timestamp":1759323227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699519301560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0211699519301560"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2019.07.002","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recomendaciones de manejo de la afectaci\u00f3n renal en el complejo esclerosis tuberosa","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2019.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}